home > Department > Department of Intractable Diseases
Intractable Diseases
Research Topic
Our goal is to understand the pathogenesis of the disease and develop pioneering therapies.
Currently, we are particularly focused on the development of cell processing technology using recombinant proteins and the development of antibody therapy against novel coronaviruses.
- Development of safe cell processing technology using peptide vectors from NCGM
- Development of antibody therapy against SARS-CoV-2 infection
- Disease development through retrotransposition induction by environmental factors
- DNA methylation changes caused by HIV-1
Main Staff
| Director | Yukihito Ishizaka |
|---|---|
| Special Fellows | Kenta Iijima Tomoki Takashina |
| Research Fellows | Shiori Haga Takuya Tada |
